Temperature-sensitive core-shell vesicle controlled-release drug carrier, preparation method and application thereof

A controlled-release drug and temperature-sensitive technology, which is applied in pharmaceutical formulations, liposome delivery, cosmetic preparations, etc., can solve the problems of not preparing a core-shell structure, short circulation period in the body, poor structural stability, etc., and achieve good Effects of rapid temperature response, good biocompatibility, and improved mechanical strength

Active Publication Date: 2011-09-28
EAST CHINA UNIV OF SCI & TECH +1
View PDF3 Cites 19 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, liposomal vesicles still exist in literature D.R.Khan, E.M.Rezler, J.L.-Fields and G.B.Fields: Chem.Biol.Drug Des.71 (2008), 3 and S.Sriwongsitanont and M.Ueno: Colloid Polym.Sci .282 (2004), 753 reported problems such as easy aggregation, settlement, and poor structural stability, as well as literature S.K.E.Messerschmidt, A.Musyanovych, M.Altvater, P.Scheurich, K.Pfizenmaier, K.Landfester and R.E.Kontermann: J. Controlled Release 137(2009), 69, literature S.Sriwongsitanont and M.Ueno: Chem.Pharm.Bull.50(9)(2002), 1238 and S.Sriwongsitanont and M.Ueno: Colloid Polym.Sci.282(2004 ), the defects reported by 753 are easy to be taken up by the reticuloendothelial system, and the circulation period in the body is short. Therefore, it is necessary to further modify and process the liposome vesicle structure
At present, although some people increase the circulation time and structural stability of liposome vesicles by modifying them, they have not been prepared into a core-shell structure, and the effect is not ideal.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Temperature-sensitive core-shell vesicle controlled-release drug carrier, preparation method and application thereof
  • Temperature-sensitive core-shell vesicle controlled-release drug carrier, preparation method and application thereof
  • Temperature-sensitive core-shell vesicle controlled-release drug carrier, preparation method and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0043] 1. Dissolve hyaluronic acid in ultrapure water at a concentration of 2 mg / mL, add triethylamine, tetrabutylammonium bromide and GMA (glycidyl methacrylate) at a weight ratio of 1:1:1, After reacting at room temperature for 10 hours, incubate at 40°C for 2 hours, freeze-dry for 2 days, and dialyze for 5 days.

[0044] 2. Add 1 mg rhodamine 6G to the phospholipid solution, transfer the solution into a round bottom flask, evaporate the solvent, and dry it in vacuum at room temperature for 2-4 hours to prepare a phospholipid film containing rhodamine 6G. After releasing the vacuum, put it into a 50-degree water bath to preheat for 20 minutes; add a buffer solution to hydrate and prepare liposomes wrapping rhodamine 6G, and make it pass through a dextran microgel column to separate the unencapsulated part. Liposomes encapsulated with Rhodamine 6G were obtained.

[0045] 3. Dilute the reaction solution obtained in step 1 with ultrapure water, add dropwise to the liposome sol...

Embodiment 2

[0052] 1. Dissolve chondroitin in ultrapure water at a concentration of 4 mg / mL, add 0.6 mL of triethylamine, 0.6 g of tetrabutylammonium bromide and 0.6 mL of GMA, react at room temperature for 20 hours, and incubate at 60°C for 2 hours. It was then freeze-dried for 5 days and dialyzed for 8 days.

[0053] 2. Add 0.5 mg rhodamine 6G to the phospholipid solution, and freeze-dry to prepare a lipid film containing rhodamine 6G. After adding buffer solution for hydration, the rhodamine 6G-encapsulated liposome is prepared, and the unencapsulated part is separated through a dextran microgel column to obtain the rhodamine 6G-encapsulated liposome.

[0054] 3. Dilute the reaction solution obtained in step 1 with ultrapure water, add dropwise to the liposome solution obtained in step 2, and sonicate for 30 minutes.

[0055] 4. Add 1 part of MBA (N, N-methylenebisacrylamide) and 10 parts of NIPAM (N-isopropylacrylamide) to the reaction solution obtained in step 3, and then add 1 part...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a temperature-sensitive core-shell vesicle controlled-release drug carrier which consists of liposome at the inner core and temperature-sensitive polymer composite gel at the outer layer. The stability of vesicle can be improved by core-shell configuration, and both the liposome at the inner core and the temperature-sensitive biological polymer composite gel at the outer layer can be used as drug carriers for carrying drugs. As the temperature raises, the gel at the outer layer varies so as to shrink, the drugs covered by the gel at the outer layer can be quickly released by means of temperature control, and the content of the liposome at the inner core can be slowly released owing to the presence of the gel at the outer layer, therefore, the effect of multidimensional release is achieved. The drug release carrier provided by the invention has outstanding biocompatibility and quick temperature response, can be used not only in the field of cosmetics, but also asthe carrier for an embedded drug, and is applied to implantation in open operation, injection in minimally invasive surgery and implantation by means of an endoscope.

Description

technical field [0001] The invention belongs to the field of pharmaceutical preparations, in particular to a core-shell structured drug carrier for controlled release, more specifically to a preparation method for polymer modification on the surface of vesicles and its application as a drug carrier. Background technique [0002] Surfactants have an amphiphilic molecular structure, and are often used to enhance interfacial activity, reduce interfacial tension, or self-assemble to form micelles and liquid crystals of various shapes, which play a role in determining the rheological properties of the interface and two-phase material transfer. It plays a very important role and has important application value in cosmetics, pharmaceuticals and various emulsification and dispersion technologies. [0003] Natural biosurfactants are a class of natural compounds with surface activity. In addition to having the same effect as general chemical surfactants, they are also safe, non-toxic,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/127A61K8/14A61K47/36
Inventor 徐首红蔺肖肖李成亮翟春涛刘洪来
Owner EAST CHINA UNIV OF SCI & TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products